Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.31 |
| ▸ | GABRD | O14764 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.31 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.31 |
| ▸ | GABRE | P78334 | 2/20 | 0.31 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.31 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.31 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.31 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL844981 | 1.00 | GABRP (0.31) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL19460394 | 0.89 | SLC6A1 (0.33) | TSHR | |
| SCHEMBL2214264 | 0.89 | SLC6A1 (0.33) | TSHR | |
| SCHEMBL16177930 | 0.82 | — | — | |
| SCHEMBL16177928 | 0.82 | — | — | |
| SCHEMBL2220133 | 0.79 | KDM4E (0.34) | TSHRKDM4E | |
| SCHEMBL1558822 | 0.79 | — | — | |
| SCHEMBL9799016 | 0.76 | — | — | |
| SCHEMBL16635021 | 0.68 | — | — | |
| SCHEMBL2466804 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5774 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122084892-A | Stable antibody conjugate for radioimmunoassay kit and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122080445-A | Sodium hyaluronate gel and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-4743059-A1 | TOPICAL ANTIOXIDANT COMPOSITIONS AND METHODS OF USING THE SAME | Alastin Skincare, Inc. (US) | 2026-05-20 | — | — | EP | claimed |
| US-12628820-B2 | Systems and methods for preservation of cells | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2026-05-19 | — | — | US | claimed |
| CN-122031325-A | Pure sunscreen lotion suitable for sensitive muscles and preparation method thereof | 上海美浮特生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026099697-A1 | CITRULLUS EXTRACTION METHOD AND USE | VAN DER MERWE PIERRE JOHANN (ZA) | 2026-05-15 | — | — | WO | claimed |
| CN-122036624-A | Preparation method of high-purity exendin | 辽宁大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122031315-A | Photoprotection synergistic composition containing red camellia extract, and preparation method and application thereof | 上海林清轩化妆品集团股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122031290-A | Percutaneous permeation promoting system and preparation method and application thereof | 北京工商大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260132436-A9 | COMPOSITIONS AND METHODS FOR RNA SYNTHESIS | HELIX NANOTECHNOLOGIES INC (US) | 2026-05-14 | — | — | US | claimed |
| WO-1999046400-A9 | COMPOSITIONS AND METHODS FOR ENHANCED SYNTHESIS OF NUCLEIC ACID MOLECULES | LIFE TECHNOLOGIES INC (US) | 2000-02-03 | — | — | WO | claimed |
| EP-0957174-A1 | Process for the separation of tetrahydropyrimidin derivatives | Degussa-Hüls Aktiengesellschaft (DE) | 1999-11-17 | — | — | EP | claimed |
| WO-1999046400-A1 | COMPOSITIONS AND METHODS FOR ENHANCED SYNTHESIS OF NUCLEIC ACID MOLECULES | LIFE TECHNOLOGIES, INC. (US) | 1999-09-16 | — | — | WO | claimed |
| US-5932781-A | GENETICALLY ENGINEERED DROUGHT- AND HIGH OSMOTIC PRESSURE RESISTANT PLANTS; DNA SEQUENCES | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1999-08-03 | — | — | US | claimed |
| EP-0915167-A1 | In vivo method of obtaining cell components | bitop Gesellschaft für biotechnische Optimierung mbH (DE) | 1999-05-12 | — | — | EP | claimed |
| EP-0887418-A2 | In vivo method of obtaining cell components | bitop Gesellschaft für biotechnische Optimierung mbH (DE) | 1998-12-30 | — | — | EP | claimed |
| EP-0677044-B1 | (IN VIVO) METHOD OF OBTAINING CELL COMPONENTS | BITOP GMBH (DE) | 1998-10-28 | — | — | EP | claimed |
| EP-0866061-A1 | Process for separating pyrimidine derivatives from aqueous solutions | Degussa Aktiengesellschaft (DE) | 1998-09-23 | — | — | EP | claimed |
| EP-0748869-A1 | ECTOINE SYNTHETASE GENE | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1996-12-18 | — | — | EP | claimed |
| EP-0671161-A1 | Ectoine and ectoine derivatives as moisturizing agents in cosmetic preparation | Marbert GmbH (DE) | 1995-09-13 | — | — | EP | claimed |